��TV

Latest news

Stay updated with our latest insights and breakthroughs

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Press releases

��TV Therapeutics reports durable clinical responses with first-in-class oral ERAP1 inhibitor GRWD5769 across six solid tumor types

Press releases

£2.5m Series A2 financing for development of therapies targeting ERAP2

Press releases

£2.5m Series A2 financing for development of therapies targeting ERAP2

In the media

��TV bags cash to advance small molecule I-O program

Press releases

GWT completes £10m ($14m) series A financing

Press releases

GWT completes £10m ($14m) series A financing

Discover how our therapies are reshaping ��TV for various diseases and conditions.

Harnessing antigen modulation to empower T cells against diseases.